BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Methoxamine

An alpha-1 adrenergic agonist that causes prolonged peripheral VASOCONSTRICTION.

300+ PubMed studies analyzed · 17 RCTs · Evidence Score: 46.6

Research Domains

Methoxamine has been studied across 18 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🦴 Bone & Joint, 🫘 Kidney, 🫁 Respiratory. The primary research focus is ❤️ Cardiovascular with 37% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Methoxamine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

rauwolscine
6 shared targets
dexniguldipine
6 shared targets
terazosin
6 shared targets
Tolazoline
6 shared targets
Indoramin
6 shared targets
clonidine
6 shared targets
naftopidil
3 shared targets
cyclazosin
3 shared targets
Rauwolfia
3 shared targets
yohimbine
3 shared targets
Loading evidence profile...

This evidence profile for Methoxamine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.